Large Pharma sign definitive Agreement to acquire stake in Aagami’s Australian client

Published : 10 Mar 2021

In August 2020, we announced that an India based large global pharma has signed a term sheet with a Biotech client of Aagami.

 

Now a definitive agreement has been signed and a public announcement has been done. Accordingly, a Subsidiary of the large India based global pharma has announced acquisition of 12.5% stake in Aagami’s Australian client for AU$2 million. The news resulted in a jump of 2% and a 52-week high in the stock price of the Pharma company.

 

We at Aagami, are proud to have succeeded in establishing this partnership for our client, despite Covid-19 situation. 

 

This is a classic example of how we at Aagami see client success, as our success. 

×
Twitter